OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The vascular bone marrow niche influences outcome in chronic myeloid leukemia via the E-selectin - SCL/TAL1 - CD44 axis
Parimala Sonika Godavarthy, Rahul Kumar, Stefanie Herkt, et al.
Haematologica (2019) Vol. 105, Iss. 1, pp. 136-147
Open Access | Times Cited: 54

Showing 26-50 of 54 citing articles:

The differential role of the lipid raft-associated protein flotillin 2 for progression of myeloid leukemia
Rahul Kumar, Raquel Pereira, Julian Niemann, et al.
Blood Advances (2022) Vol. 6, Iss. 12, pp. 3611-3624
Open Access | Times Cited: 11

The Role and Mechanism of the Vascular Endothelial Niche in Diseases: A Review
Zhiqiang Lei, Xiang Hu, Yaoqi Wu, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 11

Distinct and targetable role of calcium-sensing receptor in leukaemia
Raquel Pereira, Rahul Kumar, Alessia Cais, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 6

Recent advances in understanding chronic myeloid leukemia: where do we stand?
Rahul Kumar, Daniela S. Krause
Faculty Reviews (2021) Vol. 10
Open Access | Times Cited: 13

Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms
Yammy Yung, Emily Lee, Hiutung Chu, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 659-659
Open Access | Times Cited: 12

Novel targeted therapies in chronic myeloid leukemia
Muhammad Sameer Ashaq, Qian Zhou, Zhuoran Li, et al.
Pharmaceutical Science Advances (2024) Vol. 2, pp. 100052-100052
Open Access | Times Cited: 1

CD44: A Stemness Driver, Regulator and Marker – all in one?
Steffen Joachim Sonnentag, Nagwa Ibrahim, Véronique Orian‐Rousseau
Stem Cells (2024) Vol. 42, Iss. 12, pp. 1031-1039
Closed Access | Times Cited: 1

Understanding the hematopoietic microenvironment in chronic myeloid leukemia: A concise review
Patricia Torres-Barrera, Héctor Mayani, Antonieta Chávez‐González
Current Research in Translational Medicine (2021) Vol. 69, Iss. 3, pp. 103295-103295
Closed Access | Times Cited: 10

From the niche to malignant hematopoiesis and back: reciprocal interactions between leukemia and the bone marrow microenvironment
Celia A. Soto, Cristina Lo Celso, Louise E. Purton, et al.
JBMR Plus (2021) Vol. 5, Iss. 10
Open Access | Times Cited: 10

Adhesion to E‐selectin primes macrophages for activation through AKT and mTOR
Julie Davies, Kristen J. Radford, Jakob Begun, et al.
Immunology and Cell Biology (2021) Vol. 99, Iss. 6, pp. 622-639
Closed Access | Times Cited: 7

Targeting adhesion to the vascular niche to improve therapy for acute myeloid leukemia
Myriam Haltalli, Cristina Lo Celso
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 6

Understanding the interaction between leukaemia stem cells and their microenvironment to improve therapeutic approaches
Leandro Marcelo Martinez, Mónica L. Guzmán
British Journal of Pharmacology (2023) Vol. 181, Iss. 2, pp. 273-282
Closed Access | Times Cited: 2

Preliminary delivery efficiency prediction of nanotherapeutics into crucial cell populations in bone marrow niche
Huijuan Chen, Anzhi Hu, Mengdi Xiao, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 6, pp. 100868-100868
Open Access | Times Cited: 2

Properties of Leukemic Stem Cells in Regulating Drug Resistance in Acute and Chronic Myeloid Leukemias
Xingjian Zhai, Xiaoyan Jiang
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1841-1841
Open Access | Times Cited: 4

Defining niche interactions to target chronic myeloid leukemia stem cells
Rebecca Mitchell, Mhairi Copland
Haematologica (2020) Vol. 105, Iss. 1, pp. 2-4
Open Access | Times Cited: 5

LncRNA IRAIN overcomes imatinib resistance in chronic myeloid leukemia via NF-κB/CD44 pathway inhibition
Xijia Wang, Yutong Hou, Yizhu Lyu, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109851-109851
Open Access

Germline mutations: many roles in leukemogenesis
Kevin Z. Chen, Rafi Kazi, Christopher C. Porter, et al.
Current Opinion in Hematology (2020) Vol. 27, Iss. 4, pp. 288-293
Open Access | Times Cited: 3

Epigenetic Modification of Mesenchymal Stromal Cells Derived from Bone Marrow and Embryonal Tumors to Facilitate Immunotherapeutic Approaches in Pediatric Malignancies
Anne Kruchen, Pascal-David Johann, Laura Rekowski, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 3, pp. 2121-2135
Open Access | Times Cited: 1

Cell Contact with Endothelial Cells Favors the In Vitro Maintenance of Human Chronic Myeloid Leukemia Stem and Progenitor Cells
Patricia Torres-Barrera, Dafné Moreno-Lorenzana, José Antonio Alvarado‐Moreno, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10326-10326
Open Access | Times Cited: 2

Transformação leucêmica do microambiente das células-tronco hematopoiéticas
Maria Thereza Carvalho Rodriguez Guisande, Lorrany Junia Lopes de Lima, Gabriel Santos Costa, et al.
Revista de Medicina (2022) Vol. 101, Iss. 6
Open Access | Times Cited: 1

In the Pipeline: Emerging Therapy for CML
Harinder Gill, Emily Lee, Pinky Mo
(2023), pp. 663-684
Closed Access

Scroll to top